Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.

@article{Fischer2002AntitumourNF,
  title={Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.},
  author={Matthias Fischer and Eckhard Dr. Fiedler and Wolfgang Ch. Marsch and Johannes Wohlrab},
  journal={The British journal of dermatology},
  year={2002},
  volume={146 4},
  pages={
          707-9
        }
}
BETA

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 53 CITATIONS, ESTIMATED 26% COVERAGE

Toxic epidermal necrolysis.

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.

  • Burns : journal of the International Society for Burn Injuries
  • 2014
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.

  • Acta dermato-venereologica
  • 2008
VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2005
2018

CITATION STATISTICS

  • 3 Highly Influenced Citations